NasdaqGS:PGNYHealthcare
Progyny (PGNY): Evaluating Whether Recent Share Price Momentum Still Leaves Upside in Its Valuation
Progyny (PGNY) has quietly outperformed the broader market over the past year, and that steady climb has investors revisiting what they are paying for this fertility benefits specialist at roughly 26 dollars a share.
See our latest analysis for Progyny.
The stock’s recent 7 day and 90 day share price returns of 5.22 percent and 20.25 percent respectively show momentum building behind Progyny’s growth story, even as the 3 year total shareholder return remains negative.
If Progyny’s run has you...